The altered base is carried by the primer rather than copied from an unchanged template at that position. After the primer anneals to its complementary target region, the mismatch remains part of the primer-template arrangement, and DNA polymerase extends from the primer. Successive PCR cycles then copy and enrich molecules that contain the planned sequence change.
Annealing provides the sequence-specific anchor that positions the intentional mismatch at the target site. Complementarity elsewhere allows the primer to bind the gene template, while the altered bases specify the variant copied during extension. This balance directs PCR toward a defined change rather than an unspecified sequence alteration.
The location of the engineered change determines the biological question. In a coding region, the altered sequence can be used to examine effects on protein structure or activity. In a regulatory sequence, it can help test how sequence variation influences gene control. Primer design therefore connects a molecular change with functional interpretation.
A PCR-based workflow begins with a target template and a synthetic primer carrying the intended sequence change. The primer anneals to its complementary region, DNA polymerase extends it, and repeated amplification produces more copies of the altered product. The enriched material can then support investigation of the selected genetic variant.
They are useful when researchers need to test a specific genetic change in a target gene. Altering a coding region enables examination of consequences for protein structure or activity, making the approach relevant to molecular biology, biotechnology, and functional genomics. The defined change provides a focused basis for linking sequence variation with function.
A primer can introduce a disease-associated variant into a target gene so its functional consequences can be examined experimentally. The same strategy supports broader functional-genomics studies by creating controlled sequence differences and observing how they affect biological function. This connects a defined genetic alteration with experimentally assessable biological outcomes.